학술논문
Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical Trial
Document Type
Article
Author
Source
In Gastro Hep Advances 2024 3(3):417-425
Subject
Language
ISSN
2772-5723